FindTrial
Sign In

Predicting recurrence of primary liver cancers after surgery

Amalgamated clinical and genetic particulars to predict recurrence patterns of primary liver cancers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900023846
Enrollment
Unknown
Registered
2019-06-14
Start date
2019-06-17
Completion date
Unknown
Last updated
2019-06-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Primary liver cancer

Interventions

Group 1:Hepatocellular carcinoma resection
Group 2:Hepatocellular carcinoma transplantation
Group 3:Intrahepatic cholangiocarcinoma resection
Group 4:Intrahepatic cholangiocarcinoma resection+adjuvant treatment

Sponsors

Shanghai Jiaotong University School of Medicine, Renji Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Agree to participate; 2. Age<80 years; 3. Distinctive characteristics of hepatocellular or intrahepatic cholangiocarcinoma by imaging studies; 4. Child-Pugh class A-B; 5. BCLC stage 0-B (hepatocellular carcinoma only); 6. AJCC stage I-IIIa; 7. ECOG performance status 0-1; 8. Within Milan criteria (hepatocellular carcinoma only).

Exclusion criteria

Exclusion criteria: 1. Refuse to participate; 2. Combined hepatocellular-cholangiocarcinoma. 3. Vascular invasion. 4. Extrahepatic metastasis. 5. Lymph node metastasis. 6. Direct extrahepatic invasion. 7. ECOG performance status >1.

Design outcomes

Primary

MeasureTime frame
Overall survival;—

Secondary

MeasureTime frame
Recurrence-free survival;—

Countries

China

Contacts

Public ContactQiang Xia

Shanghai Jiaotong University School of Medicine, Renji Hospital

xiaqiang@shsmu.edu.cn+86 21 68383775

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026